Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Predicting adverse events of cancer medicines: a secondary analysis of clinical trial data

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: SORICH, Michael (Flinders University, Adelaide, Australia)
  • Co-author(s): Michael Sorich: Clinical Pharmacology, Flinders University, Adelaide, Australia
    Andrew Rowland: Clinical Pharmacology, Flinders University, Adelaide, Australia
    Ganessan Kichenadasse: Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, Australia
    Richard Woodman: Flinders Centre for Epidemiology and Biostatistics, Flinders University, Adelaide, Australia
    Arduino Mangoni: Clinical Pharmacology, Flinders University, Adelaide, Australia
  • Abstract:

    Backgrounds

    Secondary analysis of pooled clinical trial data is an important means of identifying patient characteristics and laboratory/biological markers that predict individuals at greatest risk of toxicities from cancer medicines. 

    Aims

    To evaluate risk factors for proteinuria in patients with metastatic renal cell carcinoma (mRCC) treated with a

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses